Mar 10, 2023

Featuring perspectives from Dr Matthew Lunning, including the following topics:

·      Introduction (00:00)

·      Case: A woman in her mid 20s with T1cN0M0, ER/PR-positive, HER2-negative breast cancer, Recurrence Score® (RS) of 26 — Dr Partridge (10:03)

·      Case: A woman in her late 20s with a 2.8-cm ER/PR-positive, HER2-positive Grade III intraductal carcinoma — Dr Miller (26:42)

·      Case: A woman in her mid 30s with a 3.5-cm ER/PR-negative, HER2-negative breast cancer with a BRCA2 mutation — Dr Partridge  (41:01)

·      Case: A woman in her early 30s with ER/PR-positive, HER2-negative inflammatory breast cancer — Dr Miller (52:28)

CME information and select publications